UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-01, Vol.30 (1), p.5-14

2018

Volltextzugriff (PDF)

180 Stereotactic ablative radiotherapy utilising volumetric modulated arc therapy

Lung cancer (Amsterdam, Netherlands), 2013, Vol.79, p.S62-S62

Harrow, S

2013

Volltextzugriff (PDF)

In Response to: ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?’ by Ostler et al. and ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No’ by Macbeth and Hughes-Davies

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-04, Vol.34 (4), p.e169-e170

2022

Volltextzugriff (PDF)

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-05, Vol.34 (5), p.288-300

2022

Volltextzugriff (PDF)

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-02, Vol.30 (2), p.101-109

2018

Volltextzugriff (PDF)

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-08, Vol.32 (8), p.481-489

2020

Volltextzugriff (PDF)

SP-0340 Challenging scenarios with oligometastatic SABRs - Where do we go now?

Radiotherapy and oncology, 2023-05, Vol.182, p.S270-S270

Harrow, S.

2023

Volltextzugriff (PDF)

161 Outcomes of concurrent chemoradiotherapy in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S59-S59

2016

Volltextzugriff (PDF)

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

ESMO open, 2022-04, Vol.7 (2), p.100445, Article 100445

2022

Volltextzugriff (PDF)

Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-10, Vol.32 (10), p.e211-e211

2020

Volltextzugriff (PDF)

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

Gene therapy, 2004-11, Vol.11 (22), p.1648-1658

2004

Volltextzugriff (PDF)

EP-1238: Thoracic re-irradiation following curative intent radiotherapy for non-small cell lung cancer

Radiotherapy and oncology, 2016-04, Vol.119, p.S586-S587

2016

Volltextzugriff (PDF)

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions

Clinical oncology (Royal College of Radiologists (Great Britain)), 2020-04, Vol.32 (4), p.250-258

2020

Volltextzugriff (PDF)

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy: Reply to Ghafoor et al

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-07, Vol.30 (7), p.456-456

2018

Volltextzugriff (PDF)

139: Assessment of radiation induced gross target volume (GTV) changes using weekly cone-beam CT (CBCT) for NSCLC

Lung cancer (Amsterdam, Netherlands), 2015, Vol.87, p.S50-S50

2015

Volltextzugriff (PDF)

151 The incidence of thoracic re-irradiation at 3 UK cancer centres following curative intent radiotherapy for non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S55-S55

2016

Volltextzugriff (PDF)

163: LungTech Stereotactic Body Radiotherapy (SBRT) of inoperable centrally located NSCLC: A phase II study in preparation for a randomised phase III trial

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S74-S75

2017

Volltextzugriff (PDF)

60: SYSTEMS-2: Generation of dose constraints for a hypofractionated, dose escalated radiotherapy regimen for malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2017, Vol.103, p.S27-S28

2017

Volltextzugriff (PDF)

Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

Annals of oncology, 2018-11, Vol.29, p.ix170-ix170

2018

Volltextzugriff (PDF)

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-11, Vol.28 (11), p.720-725

2016

Volltextzugriff (PDF)

P05.12 Hospitalisation Rate in Radical Re-Irradiation of NSCLC are no Different Between Local Recurrences or Second Primaries

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S273-S274

2021

Volltextzugriff (PDF)

191 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) – a feasibility study

Lung cancer (Amsterdam, Netherlands), 2016, Vol.91, p.S69-S70

2016

Volltextzugriff (PDF)

Quantitative PCR to detect Gaeumannomyces graminis var. tritici in symptomatic and non-symptomatic wheat roots

Australasian plant pathology, 2015-11, Vol.44 (6), p.591-597

2015

Volltextzugriff (PDF)

PO-0658: Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study

Radiotherapy and oncology, 2015-04, Vol.115, p.S320-S320

2015

Volltextzugriff (PDF)

EP-1937: UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus

Radiotherapy and oncology, 2016-04, Vol.119, p.S919-S919

2016

Volltextzugriff (PDF)

1 – 25 von 2.322

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.689)
Mit Volltextzugriff
(1.736)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(790)
Life Sciences & Biomedicine
(641)
Humans
(493)
Male
(254)
Female
(252)
Biological And Medical Sciences
(206)
Adult
(202)
Psychiatry
(176)
Social Sciences
(150)
Middle Aged
(129)
Medical Sciences
(127)
Animals
(114)
Schizophrenic Psychology
(93)
Literature
(91)
Schizophrenia
(90)
Fundamental And Applied Biological Sciences. Psychology
(85)
Physical Sciences
(82)
Psychology. Psychoanalysis. Psychiatry
(82)
Psychopathology. Psychiatry
(81)
Adult And Adolescent Clinical Studies
(76)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

180 Stereotactic ablative radiotherapy utilising volumetric modulated arc therapy

In Response to: ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?’ by Ostler et al. and ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No’ by Macbeth and Hughes-Davies

UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

SP-0340 Challenging scenarios with oligometastatic SABRs - Where do we go now?

161 Outcomes of concurrent chemoradiotherapy in small cell lung cancer

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

EP-1238: Thoracic re-irradiation following curative intent radiotherapy for non-small cell lung cancer

Toxicity and Efficacy of Stereotactic Ablative Body Radiotherapy for Moderately Central Non-small Cell Lung Cancers Using 50 Gy in Five Fractions

UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy: Reply to Ghafoor et al

139: Assessment of radiation induced gross target volume (GTV) changes using weekly cone-beam CT (CBCT) for NSCLC

151 The incidence of thoracic re-irradiation at 3 UK cancer centres following curative intent radiotherapy for non-small cell lung cancer

163: LungTech Stereotactic Body Radiotherapy (SBRT) of inoperable centrally located NSCLC: A phase II study in preparation for a randomised phase III trial

60: SYSTEMS-2: Generation of dose constraints for a hypofractionated, dose escalated radiotherapy regimen for malignant pleural mesothelioma

Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

P05.12 Hospitalisation Rate in Radical Re-Irradiation of NSCLC are no Different Between Local Recurrences or Second Primaries

191 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) – a feasibility study

Quantitative PCR to detect Gaeumannomyces graminis var. tritici in symptomatic and non-symptomatic wheat roots

PO-0658: Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study

EP-1937: UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus

Suchergebnisse filtern